VJHemOnc is committed to improving our service to you

COMy 2020 | COMy 2020 highlights: smoldering myeloma, MRD and immunotherapy

VJHemOnc is committed to improving our service to you

Arnon Nagler

Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, gives an overview of the topics discussed during the COMy 2020 meeting. The main areas of discussion this year were smoldering myeloma, new drugs approved for multiple myeloma, CAR T-cell therapies and new monoclonal antibodies. The role of MRD in multiple myeloma was also discussed. The meeting this year was very successful with attendees from over 100 countries and thousands of people watching. This interview took place during the Controversies in Multiple Myeloma (COMy) 2020 Virtual World Congress.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter